Recursion Pharmaceuticals
RXRX
#4001
Rank
HK$18.27 B
Marketcap
HK$47.01
Share price
-3.67%
Change (1 day)
-12.06%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: HK$18.27 Billion

As of November 2024 Recursion Pharmaceuticals has a market cap of HK$18.27 Billion. This makes Recursion Pharmaceuticals the world's 4001th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$18.27 B9.94%
2023HK$16.62 B45.58%
2022HK$11.41 B-49.41%
2021HK$22.57 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Recursion Pharmaceuticals was reported to be:

HK$13.47 Billion
by Nasdaq info icon info icon
HK$13.47 Billion
by CompaniesMarketCap info icon info icon